Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CCH Histopathology in Abdominoplasty Model
NCT04236635Phase 2Completed
- Sponsor
- Endo International plc
- Start
- Dec 2019
- Primary completion
- Sep 2020
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of collagenase clostridium histolyticum in cellulite (6 arms), sponsored by Endo International plc. Primary endpoint: Number of Participants With a Histologic Change in a Tissue Specimen That Was Injected With CCH at Day 0. Started Dec 2019; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
cellulite
Beyond the preview
Go deeper on NCT04236635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04236635.